Alfentanil in anesthesia and analgesia.
Alfentanil is a tetrazole derivative of fentanyl. Many of the pharmacologic effects of alfentanil are similar to those of fentanyl and sufentanil, but of quicker onset than those of fentanyl and of shorter duration than those of fentanyl and sufentanil. Alfentanil may cause less intense respiratory depression than equianalgesic doses of fentanyl. Alfentanil has a lower total body clearance, smaller volume of distribution, and shorter half-life than fentanyl and sufentanil. Clinical trials indicate alfentanil can be used effectively as an analgesic, an analgesic supplement to anesthesia, an anesthetic induction agent, and as the major component of a general anesthetic. Its short duration of effect makes it attractive as an analgesic supplement for short ambulatory surgical procedures. Alfentanil is recommended for addition to drug formularies, but its use should be restricted to anesthesia personnel.
D015760:Alfentanil; D000698:Analgesia; D000758:Anesthesia; D001798:Blood Proteins / Q000378:metabolism; D004339:Drug Compounding; D004347:Drug Interactions; D005283:Fentanyl / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D005569:Formularies as Topic; D006801:Humans; D010146:Pain / Q000188:drug therapy; D011485:Protein Binding
D001798:Blood Proteins; D015760:Alfentanil; D005283:Fentanyl